Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Tomashek, Km"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 47
Tytuł:
U.S. Maternally linked birth records may be biased for Hispanics and other population groups.
Autorzy:
Leiss JK (AUTHOR)
Giles D (AUTHOR)
Sullivan KM (AUTHOR)
Mathews R (AUTHOR)
Sentelle G (AUTHOR)
Tomashek KM (AUTHOR)
Leiss, Jack K (AUTHOR)
Giles, Denise (AUTHOR)
Sullivan, Kristin M (AUTHOR)
Mathews, Rahel (AUTHOR)
Sentelle, Glenda (AUTHOR)
Tomashek, Kay M (AUTHOR)
Pokaż więcej
Źródło:
Annals of Epidemiology. Jan2010, Vol. 20 Issue 1, p23-31. 9p.
Czasopismo naukowe
Szczegóły
Tytuł:
Evaluating Demographic Representation in Clinical Trials: Use of the Adaptive Coronavirus Disease 2019 Treatment Trial (ACTT) as a Test Case.
Autorzy:
Ortega-Villa AM; Biostatistics Research Branch, Division of Clinical Research, National Institute of Allergy and Infectious Diseases, Rockville, Maryland, USA.
Hynes NA; Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Levine CB; Division of Infectious Disease, Department of Internal Medicine, University of Texas Medical Branch, Galveston, Texas, USA.
Yang K; Department of Clinical Pharmacy, University of California, San Francisco, San Francisco, California, USA.
Wiley Z; Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA.
Jilg N; Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.; Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Wang J; Clinical Monitoring Research Program Directorate, Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA.
Whitaker JA; Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas, USA.
Colombo CJ; Department of Virtual Health and Department of Medicine, Madigan Army Medical Center, Tacoma, Washington, USA.; Department of Medicine, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.
Nayak SU; Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
Kim HJ; Department of Community Health Systems, School of Nursing, University of California, San Francisco, San Francisco, California, USA.; National Patient Care Services, Kaiser Permanente, Oakland, California, USA.
Iovine NM; Division of Infectious Diseases and Global Medicine, Department of Medicine, University of Florida Health, Gainesville, Florida, USA.
Ince D; Division of Infectious Diseases, Department of Internal Medicine, University of Iowa, Iowa City, Iowa, USA.
Cohen SH; Division of Infectious Diseases, University of California, Davis, Sacramento, California, USA.
Langer AJ; COVID-19 Emergency Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Wortham JM; COVID-19-Associated Hospitalization Surveillance Network, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Atmar RL; Department of Medicine, Baylor College of Medicine, Houston, Texas, USA.
El Sahly HM; Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas, USA.
Jain MK; Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Mehta AK; Division of Infection Diseases, Emory University School of Medicine, Atlanta, Georgia, USA.; National Emerging Special Pathogens Treatment and Education Center, Atlanta, Georgia, USA.
Wolfe CR; Division of Infectious Diseases, Department of Medicine, Duke University Medical Center, Durham, North Carolina, USA.
Gomez CA; Division of Infectious Diseases, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, Nebraska, USA.
Beresnev T; Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
Mularski RA; Department of Pulmonary and Critical Care Medicine, Northwest Permanente, Kaiser Permanente Northwest, Portland, Oregon, USA.; The Center for Health Research, Kaiser Permanente Northwest, Portland, Oregon, USA.
Paules CI; Division of Infectious Diseases, Penn State Health Milton S. Hershey Medical Center, Hershey, Pennsylvania, USA.
Kalil AC; Division of Infectious Diseases, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, Nebraska, USA.
Branche AR; Division of Infectious Diseases, Department of Medicine, University of Rochester Medical Center, Rochester, New York, USA.
Luetkemeyer A; Department of Medicine, University of California, San Francisco, San Francisco, California, USA.
Zingman BS; Department of Medicine, Montefiore Medical Center, University Hospital for Albert Einstein College of Medicine, Bronx, New York, USA.
Voell J; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
Whitaker M; COVID-19-Associated Hospitalization Surveillance Network, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Harkins MS; Division of Pulmonary and Critical Care, Department of Internal Medicine, University of New Mexico Health Sciences Center, Albuquerque, New Mexico, USA.
Davey RT Jr; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
Grossberg R; Division of Infectious Diseases, Department of Medicine, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, New York, USA.
George SL; Department of Internal Medicine, Saint Louis University and St Louis Veterans Affairs Medical Center, St Louis, Missouri, USA.
Tapson V; Division of Pulmonary and Critical Care, Cedars-Sinai Medical Center, Los Angeles, California, USA.
Short WR; Division of Infectious Diseases, Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Ghazaryan V; Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
Benson CA; Division of Infectious Diseases and Global Public Health, University of California, San Diego, San Diego, California, USA.
Dodd LE; Biostatistics Research Branch, Division of Clinical Research, National Institute of Allergy and Infectious Diseases, Rockville, Maryland, USA.
Sweeney DA; Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, University of California, San Diego, San Diego, California, USA.
Tomashek KM; Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
Pokaż więcej
Źródło:
Open forum infectious diseases [Open Forum Infect Dis] 2023 May 27; Vol. 10 (6), pp. ofad290. Date of Electronic Publication: 2023 May 27 (Print Publication: 2023).
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Baricitinib Treatment of Coronavirus Disease 2019 Is Associated With a Reduction in Secondary Infections.
Autorzy:
Sweeney DA; Department of Medicine, University of California San Diego, La Jolla, CA, USA.
Tuyishimire B; The Emmes Company, LLC, Rockville, MD, USA.
Ahuja N; Department of Medicine, Stanford University, Palo Alto, CA, USA.
Beigel JH; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
Beresnev T; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
Cantos VD; Department of Medicine, Emory University, Atlanta, GA, USA.
Castro JG; Department of Medicine, University of Miami, Miami, FL, USA.
Cohen SH; Department of Internal Medicine, University of California Davis, Sacramento, CA, USA.
Cross K; The Emmes Company, LLC, Rockville, MD, USA.
Dodd LE; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
Erdmann N; Department of Medicine, University of Alabama at Birmingham (UAB), Birmingham, AL, USA.
Fung M; Department of Medicine, University of California San Francisco, San Francisco, CA, USA.
Ghazaryan V; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
George SL; Department of Medicine, Saint Louis University and St. Louis VA Medical Center, Saint Louis, MO, USA.
Grimes KA; Department of Medicine, Houston Methodist, Houston, TX, USA.
Hynes NA; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Julian KG; Department of Medicine, Pennsylvania State Health Milton S. Hershey Medical Center, Hershey, PA, USA.
Kandiah S; Department of Medicine, Emory University, Atlanta, GA, USA.
Kim HJ; Community Health Systems Department, University of California San Francisco, San Francisco, CA, USA.; Department of Nursing, Kaiser Permanente National Patient Care Services, Oakland, CA, USA.
Levine CB; Department of Internal Medicine Galveston, University of Texas Medical Branch, TX, USA.
Lindholm DA; Department of Medicine, Uniformed Services University of the Health Sciences, Bethesda, MD, USA.; Department of Medicine, Brooke Army Medical Center, Joint Base San Antonio-Ft Sam Houston, TX, USA.
Lye DC; National Centre for Infectious Diseases, Singapore, Singapore.; Department of Infectious Diseases, Tan Tock Seng Hospital, Singapore, Singapore.; Lee Kong Chian School of Medicine, Singapore, Singapore.; Yong Loo Lin School of Medicine, Singapore, Singapore.
Maves RC; Departments of Internal Medicine and Anesthesiology, Wake Forest University, Winston-Salem, NC, USA.
Oh MD; Department of Internal Medicine, Seoul National University Hospital College of Medicine, Seoul, Korea.
Paules C; Department of Medicine, Pennsylvania State Health Milton S. Hershey Medical Center, Hershey, PA, USA.
Rapaka RR; Department of Medicine, Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, USA.
Short WR; Department of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Tomashek KM; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
Wolfe CR; Department of Medicine, Duke University, Durham, NC, USA.
Kalil AC; Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE, USA.
Pokaż więcej
Źródło:
Open forum infectious diseases [Open Forum Infect Dis] 2023 Apr 19; Vol. 10 (5), pp. ofad205. Date of Electronic Publication: 2023 Apr 19 (Print Publication: 2023).
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Challenges and lessons learned from the rapid operationalization of a prospective cohort to study the natural history and neurodevelopmental outcomes of postnatal Zika virus infection among infants and children in rural Guatemala.
Autorzy:
Paniagua-Avila A; Center for Human Development, Fundacion para la Salud Integral de los Guatemaltecos, Retalhuleu, Guatemala.; Department of Epidemiology, Mailman School of Public Health, Columbia University, New York City, New York, United States of America.
Olson D; Center for Human Development, Fundacion para la Salud Integral de los Guatemaltecos, Retalhuleu, Guatemala.; Center for Global Health, Colorado School of Public Health, Aurora, Colorado, United States of America.; Department of Pediatrics, University of Colorado School of Medicine, Aurora, Colorado, United States of America.
Connery A; Center for Human Development, Fundacion para la Salud Integral de los Guatemaltecos, Retalhuleu, Guatemala.; Department of Rehabilitation Medicine, University of Colorado School of Medicine, Aurora, Colorado, United States of America.
Calvimontes DM; Center for Human Development, Fundacion para la Salud Integral de los Guatemaltecos, Retalhuleu, Guatemala.
Bolanos GA; Center for Human Development, Fundacion para la Salud Integral de los Guatemaltecos, Retalhuleu, Guatemala.; Department of Epidemiology, Mailman School of Public Health, Columbia University, New York City, New York, United States of America.
Lamb MM; Department of Epidemiology, Mailman School of Public Health, Columbia University, New York City, New York, United States of America.
Bauer D; Center for Human Development, Fundacion para la Salud Integral de los Guatemaltecos, Retalhuleu, Guatemala.; Department of Epidemiology, Mailman School of Public Health, Columbia University, New York City, New York, United States of America.
Ralda A; Center for Human Development, Fundacion para la Salud Integral de los Guatemaltecos, Retalhuleu, Guatemala.
Rojop N; Center for Human Development, Fundacion para la Salud Integral de los Guatemaltecos, Retalhuleu, Guatemala.
Barrios E; Center for Human Development, Fundacion para la Salud Integral de los Guatemaltecos, Retalhuleu, Guatemala.
Chacon A; Center for Human Development, Fundacion para la Salud Integral de los Guatemaltecos, Retalhuleu, Guatemala.
Gomez M; Center for Human Development, Fundacion para la Salud Integral de los Guatemaltecos, Retalhuleu, Guatemala.
Arroyave P; Center for Human Development, Fundacion para la Salud Integral de los Guatemaltecos, Retalhuleu, Guatemala.
Hernandez S; Center for Human Development, Fundacion para la Salud Integral de los Guatemaltecos, Retalhuleu, Guatemala.
Martinez MA; Center for Human Development, Fundacion para la Salud Integral de los Guatemaltecos, Retalhuleu, Guatemala.
Bunge-Montes S; Center for Human Development, Fundacion para la Salud Integral de los Guatemaltecos, Retalhuleu, Guatemala.
Colbert A; Department of Rehabilitation Medicine, University of Colorado School of Medicine, Aurora, Colorado, United States of America.
Arias K; Center for Human Development, Fundacion para la Salud Integral de los Guatemaltecos, Retalhuleu, Guatemala.
Brazeale G; Center for Human Development, Fundacion para la Salud Integral de los Guatemaltecos, Retalhuleu, Guatemala.; Center for Global Health, Colorado School of Public Health, Aurora, Colorado, United States of America.
Holliday A; Emmes Company, LLC, Rockville, Maryland, United States of America.
Tomashek KM; Emmes Company, LLC, Rockville, Maryland, United States of America.
El Sahly HM; Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, Maryland, United States of America.; Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas, United States of America.
Keitel W; Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, Maryland, United States of America.; Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas, United States of America.
Munoz FM; Department of Medicine, Section of Infectious Diseases, Baylor College of Medicine, Houston, Texas, United States of America.; Department of Pediatrics, Section of Infectious Diseases, Baylor College of Medicine, Houston, Texas, United States of America.
Asturias EJ; Center for Human Development, Fundacion para la Salud Integral de los Guatemaltecos, Retalhuleu, Guatemala.; Center for Global Health, Colorado School of Public Health, Aurora, Colorado, United States of America.; Department of Pediatrics, University of Colorado School of Medicine, Aurora, Colorado, United States of America.
Pokaż więcej
Źródło:
PLoS neglected tropical diseases [PLoS Negl Trop Dis] 2022 Nov 16; Vol. 16 (11), pp. e0010480. Date of Electronic Publication: 2022 Nov 16 (Print Publication: 2022).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
MeSH Terms:
Zika Virus Infection*
Zika Virus*
Pregnancy Complications, Infectious*/epidemiology
Infant ; Child ; Female ; Humans ; Child, Preschool ; Pregnancy ; Cohort Studies ; Prospective Studies ; Guatemala/epidemiology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Clinical Features and Treatment Outcomes of Pulmonary Mycobacterium avium-intracellulare Complex With and Without Coinfections.
Autorzy:
Wang G; Department of Internal Medicine, Saint Louis University, St Louis, Missouri, USA.
Stapleton JT; Department of Internal Medicine, University of Iowa, Iowa City, Iowa, USA.
Baker AW; Duke University School of Medicine, Durham, North Carolina, USA.
Rouphael N; Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA.
Creech CB; Vanderbilt Vaccine Research Program, Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
El Sahly HM; Baylor College of Medicine, Human Vaccine Institute, Houston, Texas, USA.
Stout JE; Duke University School of Medicine, Durham, North Carolina, USA.
Jackson L; Kaiser Permanente Washington Health Research Institute, Seattle, Washington, USA.
Charbek E; Department of Internal Medicine, Saint Louis University, St Louis, Missouri, USA.
Leyva FJ; Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland, USA.
Tomashek KM; Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland, USA.
Tibbals M; Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland, USA.
Miller A; Department of Internal Medicine, Saint Louis University, St Louis, Missouri, USA.
Frey S; Department of Internal Medicine, Saint Louis University, St Louis, Missouri, USA.
Niemotka S; Department of Internal Medicine, Saint Louis University, St Louis, Missouri, USA.
Wiemken TL; Department of Internal Medicine, Saint Louis University, St Louis, Missouri, USA.
Beydoun N; Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA.
Alaaeddine G; Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA.
Turner N; Duke University School of Medicine, Durham, North Carolina, USA.
Walter EB; Duke University School of Medicine, Durham, North Carolina, USA.
Chamberland R; Department of Pathology, Division of Clinical Pathology, Saint Louis University School of Medicine, St Louis, Missouri, USA.
Abate G; Department of Internal Medicine, Saint Louis University, St Louis, Missouri, USA.
Pokaż więcej
Źródło:
Open forum infectious diseases [Open Forum Infect Dis] 2022 Jul 26; Vol. 9 (8), pp. ofac375. Date of Electronic Publication: 2022 Jul 26 (Print Publication: 2022).
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
The detection of anti-dengue virus IgM in urine in participants enrolled in an acute febrile illness study in Puerto Rico.
Autorzy:
Caraballo E; University of Puerto Rico, UPR- Comprehensive Cancer Center(UPRCCC), Division of Cancer Biology, San Juan, Puerto Rico.
Poole-Smith BK; Armed Forces Research Institute of Medical Sciences (AFRIMS), Bangkok, Thailand.
Tomashek KM; National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID), Division of Microbiology and Infectious Diseases (DMID), Office of Clinical Research Resources (OCRR).
Torres-Velasquez B; Centers for Disease Control and Prevention (CDC), Division of Vector Borne Diseases, San Juan, Puerto Rico.
Alvarado LI; Ponce Health Science University, Ponce, Puerto Rico.
Lorenzi OD; Centers for Disease Control and Prevention (CDC), Division of Vector Borne Diseases, San Juan, Puerto Rico.
Ramos C; Centers for Disease Control and Prevention (CDC), Division of Vector Borne Diseases, San Juan, Puerto Rico.
Carrión J; Centers for Disease Control and Prevention (CDC), Division of Vector Borne Diseases, San Juan, Puerto Rico.
Hunsperger E; CDC, Division of Global Health Protection, Epidemiology, Surveillance, Informatics, and Laboratory Branch, CDC-Kenya.
Pokaż więcej
Źródło:
PLoS neglected tropical diseases [PLoS Negl Trop Dis] 2020 Jan 29; Vol. 14 (1), pp. e0007971. Date of Electronic Publication: 2020 Jan 29 (Print Publication: 2020).
Typ publikacji:
Journal Article
MeSH Terms:
Antibodies, Viral/*urine
Dengue/*diagnosis
Dengue/*urine
Dengue Virus/*immunology
Immunoglobulin M/*urine
Adolescent ; Adult ; Child ; Dengue/epidemiology ; Diagnostic Tests, Routine/methods ; Female ; Fever/diagnosis ; Humans ; Male ; Middle Aged ; Puerto Rico/epidemiology ; Sensitivity and Specificity ; Young Adult
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Distinguishing patients with laboratory-confirmed chikungunya from dengue and other acute febrile illnesses, Puerto Rico, 2012-2015.
Autorzy:
Alvarado LI; Ponce Health Sciences University /Ponce Research Institute, Saint Luke's Episcopal Hospital, Ponce, Puerto Rico, United States of America.
Lorenzi OD; Dengue Branch, Division of Vector-Borne Diseases, Centers for Disease Control and Prevention (CDC), San Juan, Puerto Rico, United States of America.
Torres-Velásquez BC; Dengue Branch, Division of Vector-Borne Diseases, Centers for Disease Control and Prevention (CDC), San Juan, Puerto Rico, United States of America.
Sharp TM; Dengue Branch, Division of Vector-Borne Diseases, Centers for Disease Control and Prevention (CDC), San Juan, Puerto Rico, United States of America.
Vargas L; Ponce Health Sciences University /Ponce Research Institute, Saint Luke's Episcopal Hospital, Ponce, Puerto Rico, United States of America.
Muñoz-Jordán JL; Dengue Branch, Division of Vector-Borne Diseases, Centers for Disease Control and Prevention (CDC), San Juan, Puerto Rico, United States of America.
Hunsperger EA; Division of Global Health Protection, Centers for Disease Control and Prevention (CDC), Kenya, Africa.
Pérez-Padilla J; Dengue Branch, Division of Vector-Borne Diseases, Centers for Disease Control and Prevention (CDC), San Juan, Puerto Rico, United States of America.
Rivera A; Dengue Branch, Division of Vector-Borne Diseases, Centers for Disease Control and Prevention (CDC), San Juan, Puerto Rico, United States of America.
González-Zeno GE; Ponce Health Sciences University /Ponce Research Institute, Saint Luke's Episcopal Hospital, Ponce, Puerto Rico, United States of America.
Galloway RL; Bacterial Special Pathogens Branch, Zoonoses and Select Agent Laboratory, CDC, Atlanta, Georgia, United States of America.
Glass Elrod M; Bacterial Special Pathogens Branch, Zoonoses and Select Agent Laboratory, CDC, Atlanta, Georgia, United States of America.
Mathis DL; Bacterial Special Pathogens Branch, Zoonoses and Select Agent Laboratory, CDC, Atlanta, Georgia, United States of America.
Oberste MS; Polio and Picornavirus Laboratory Branch, Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, CDC, Atlanta, Georgia, United States of America.
Nix WA; Polio and Picornavirus Laboratory Branch, Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, CDC, Atlanta, Georgia, United States of America.
Henderson E; Polio and Picornavirus Laboratory Branch, Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, CDC, Atlanta, Georgia, United States of America.
McQuiston J; Rickettsial Zoonoses Branch, Division of Vector-Borne Diseases, CDC, Atlanta, Georgia, United States of America.
Singleton J; Rickettsial Zoonoses Branch, Division of Vector-Borne Diseases, CDC, Atlanta, Georgia, United States of America.
Kato C; Rickettsial Zoonoses Branch, Division of Vector-Borne Diseases, CDC, Atlanta, Georgia, United States of America.
García-Gubern C; Ponce Health Sciences University /Ponce Research Institute, Saint Luke's Episcopal Hospital, Ponce, Puerto Rico, United States of America.
Santiago-Rivera W; Ponce Health Sciences University /Ponce Research Institute, Saint Luke's Episcopal Hospital, Ponce, Puerto Rico, United States of America.
Muns-Sosa R; Saint Luke's Episcopal Hospital, Guayama, Puerto Rico, United States of America.
Ortiz-Rivera JD; Saint Luke's Episcopal Hospital, Guayama, Puerto Rico, United States of America.
Jiménez G; Saint Luke's Episcopal Hospital, Guayama, Puerto Rico, United States of America.
Rivera-Amill V; Ponce Health Sciences University /Ponce Research Institute, Saint Luke's Episcopal Hospital, Ponce, Puerto Rico, United States of America.
Andújar-Pérez DA; Ponce Health Sciences University /Ponce Research Institute, Saint Luke's Episcopal Hospital, Ponce, Puerto Rico, United States of America.
Horiuchi K; Office of the Director, Division of Vector-Borne Diseases, CDC, Fort Collins, Colorado, United States of America.
Tomashek KM; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.
Pokaż więcej
Źródło:
PLoS neglected tropical diseases [PLoS Negl Trop Dis] 2019 Jul 22; Vol. 13 (7), pp. e0007562. Date of Electronic Publication: 2019 Jul 22 (Print Publication: 2019).
Typ publikacji:
Journal Article; Research Support, U.S. Gov't, P.H.S.
MeSH Terms:
Chikungunya Fever/*diagnosis
Dengue/*diagnosis
Fever/*diagnosis
Adolescent ; Adult ; Child ; Child, Preschool ; Clinical Laboratory Techniques ; Diagnosis, Differential ; Female ; Humans ; Male ; Middle Aged ; Predictive Value of Tests ; Puerto Rico ; Real-Time Polymerase Chain Reaction ; Young Adult
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Development of standard clinical endpoints for use in dengue interventional trials: introduction and methodology.
Autorzy:
Jaenisch T; Section Clinical Tropical Medicine, Department of Infectious Diseases, Heidelberg University Hospital, Heidelberg, Germany.
Hendrickx K; Postdoctoral Fellow of the Research Foundation - Flanders (FWO) and Research Associate of Spiral, Université de Liège, Liège, Belgium.; Mesydel, SPIRAL Research Center, Département de Science Politique, Université de Liège, Liège, Belgium.
Erpicum M; Mesydel, SPIRAL Research Center, Département de Science Politique, Université de Liège, Liège, Belgium.
Agulto L; Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD, USA.
Tomashek KM; Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD, USA.
Dempsey W; Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD, USA.
Siqueira JB; Federal University of Goias, Goiânia, Brazil.
Marks MA; Pharmacoepidemiology Department, Merck & Co., Inc., Kenilworth, New Jersey, USA.
Fay MP; Biostatistics Research Branch, Division of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD, USA.
Laughlin C; Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD, USA.
L'Azou M; Global Epidemiology, Sanofi-Pasteur, Lyon, France.
Leo YS; Institute of Infectious Disease and Epidemiology, Tan Tock Seng Hospital, and National Centre for Infectious Diseases MOH, Singapore, Singapore.
Narvaez F; Infectious Diseases Unit, National Pediatric Reference Hospital, Hospital Infantil Manuel de Jesús Rivera, Managua, Nicaragua.
Teyssou R; Partnership for Dengue Control, Fondation Merieux, Lyon, France.; Unité de Virologie, Institut de Recherche Biomédicale des Armées, Brétigny-rur-Orge, France.
Thomas SJ; Division of Infectious Diseases, State University of New York, Upstate Medical University, Syracuse, NY, USA.
Tissera H; National Dengue Control Unit, Ministry of Health, Colombo, Sri Lanka.
Wallace D; Takeda Pharmaceuticals International AG, Zurich, Switzerland.
Wilder-Smith A; Partnership for Dengue Control, Fondation Merieux, Lyon, France.; Lee Kong Chian School of Medicine, Nayang Technological University, Singapore, Singapore.
Gubler DJ; Partnership for Dengue Control, Fondation Merieux, Lyon, France.; Emerging Infectious Diseases Programme, Duke-NUS Medical School, Singapore, Singapore.
Cassetti MC; Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD, USA. .
Pokaż więcej
Źródło:
BMC medical research methodology [BMC Med Res Methodol] 2018 Nov 15; Vol. 18 (1), pp. 134. Date of Electronic Publication: 2018 Nov 15.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Clinical Trials as Topic*
Dengue/*prevention & control
Dengue Vaccines/*therapeutic use
Endpoint Determination/*methods
Delphi Technique ; Dengue/therapy ; Dengue Vaccines/administration & dosage ; Endpoint Determination/standards ; Hospitalization/statistics & numerical data ; Humans ; Outcome Assessment, Health Care/methods ; Outcome Assessment, Health Care/standards ; Reproducibility of Results
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Dengue illness index-A tool to characterize the subjective dengue illness experience.
Autorzy:
Thomas SJ; Division of Infectious Diseases, State University of New York, Upstate Medical University, Syracuse, NY, United States of America.
Agulto L; Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD, United States of America.
Hendrickx K; FWO Postdoctoral Fellow of the Life Sciences & Society Lab, Center for Sociological Research, KU Leuven, Flanders, Belgium.; SPIRAL Research Center, Département de Science Politique, Université de Liège, Liège, Belgium.
Erpicum M; SPIRAL Research Center, Département de Science Politique, Université de Liège, Liège, Belgium.
Tomashek KM; Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD, United States of America.
Cassetti MC; Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD, United States of America.
Laughlin C; Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD, United States of America.
Precioso A; Division of Clinical Trials and Pharmacovigilance, Butantan Institute, São Paulo, Brazil.; Pediatrics Department of the Medical School of University of São Paulo, São Paulo, Brazil.
Schmidt AC; GSK Vaccines, Rockville, MD, United States of America.
Narvaez F; Infectious Diseases Unit, National Pediatric Reference Hospital, Hospital Infantil Manuel de Jesús Rivera, Managua, Nicaragua.
Siqueira JB; Federal University of Goias, Brasilia, Brazil.
Tissera H; National Dengue Control Unit, Ministry of Health, Colombo, Sri Lanka.
Edelman R; Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, MD, United States of America.
Pokaż więcej
Źródło:
PLoS neglected tropical diseases [PLoS Negl Trop Dis] 2018 Oct 04; Vol. 12 (10), pp. e0006593. Date of Electronic Publication: 2018 Oct 04 (Print Publication: 2018).
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Severity of Illness Index*
Dengue/*diagnosis
Dengue/*pathology
Clinical Trials as Topic/methods ; Dengue/drug therapy ; Dengue/prevention & control ; Drug Evaluation, Preclinical/methods ; Humans ; Prospective Studies ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Development of standard clinical endpoints for use in dengue interventional trials.
Autorzy:
Tomashek KM; Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland, United States of America (USA).
Wills B; Oxford University Clinical Research Unit, Hospital for Tropical Diseases, Ho Chi Minh City, Viet Nam.
See Lum LC; Department of Paediatrics, University of Malaya, Kuala Lumpur, Malaysia.
Thomas L; Emergency Department, University Hospital of Martinique, Fort-de-France, Martinique.
Durbin A; Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America.
Leo YS; Institute of Infectious Diseases and Epidemiology, Tan Tock Seng Hospital, Singapore.
de Bosch N; Universidad Central de Venezuela, Caracas, Venezuela.
Rojas E; Escuela de Medicina, Universidad Industrial de Santander, Bucaramanga, Colombia.
Hendrickx K; FWO Postdoctoral Fellow of the Life Sciences & Society Lab, Center for Sociological Research, KU Leuven and Research Associate of SPIRAL Research Center, University of Liège, Belgium.
Erpicum M; SPIRAL Research Center, University of Liège, Belgium.
Agulto L; Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland, United States of America (USA).
Jaenisch T; Department of Infectious Diseases, Heidelberg University Hospital, Heidelberg, Germany.
Tissera H; National Dengue Control Unit, Ministry of Health, Elvitigala Mawatha, Colombo, Sri Lanka.
Suntarattiwong P; Department of Pediatrics, Queen Sirikit National Institute of Child Health, Bangkok, Thailand.
Collers BA; Merck & Co. Inc., Kenilworth, New Jersey, United States of America.
Wallace D; Takeda Pharmaceutical Co. Ltd., Zurich, Switzerland.
Schmidt AC; GlaxoSmithKline plc (GSK) Vaccines, Rockville, Maryland, United States of America.
Precioso A; Division of Clinical Trials and Pharmacovigilance, Butantan Institute, São Paulo, Brazil.; Pediatrics Department of the Medical School of University of São Paulo, São Paulo, Brazil.
Narvaez F; Infectious Diseases Unit, National Pediatric Reference Hospital, Hospital Infantil Manuel de Jesús Rivera, Managua, Nicaragua.
Thomas SJ; Division of Infectious Diseases, State University of New York, Upstate Medical University, Syracuse, New York, United States of America.
Edelman R; Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, Maryland, United States of America.
Siqueira JB; Federal University of Goias, Brasilia, Brazil.
Cassetti MC; Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland, United States of America (USA).
Dempsey W; Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland, United States of America (USA).
Gubler DJ; Emerging Infectious Diseases Programme, Duke-NUS Medical School, Singapore.
Pokaż więcej
Źródło:
PLoS neglected tropical diseases [PLoS Negl Trop Dis] 2018 Oct 04; Vol. 12 (10), pp. e0006497. Date of Electronic Publication: 2018 Oct 04 (Print Publication: 2018).
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Endpoint Determination*
Clinical Trials as Topic/*methods
Dengue/*drug therapy
Dengue/*prevention & control
Adolescent ; Adult ; Aged ; Aged, 80 and over ; Antiviral Agents/therapeutic use ; Child ; Child, Preschool ; Clinical Trials as Topic/standards ; Dengue/diagnosis ; Dengue/pathology ; Dengue Vaccines/immunology ; Female ; Humans ; Infant ; Infant, Newborn ; Male ; Middle Aged ; Treatment Outcome ; Young Adult
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Estimating dengue under-reporting in Puerto Rico using a multiplier model.
Autorzy:
Shankar MB; Division of Preparedness and Emerging Infections, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, United States of America.
Rodríguez-Acosta RL; Dengue Branch, Division of Vector-Borne Diseases, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, San Juan, Puerto Rico.
Sharp TM; Dengue Branch, Division of Vector-Borne Diseases, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, San Juan, Puerto Rico.
Tomashek KM; Dengue Branch, Division of Vector-Borne Diseases, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, San Juan, Puerto Rico.
Margolis HS; Dengue Branch, Division of Vector-Borne Diseases, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, San Juan, Puerto Rico.
Meltzer MI; Division of Preparedness and Emerging Infections, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, United States of America.
Pokaż więcej
Źródło:
PLoS neglected tropical diseases [PLoS Negl Trop Dis] 2018 Aug 06; Vol. 12 (8), pp. e0006650. Date of Electronic Publication: 2018 Aug 06 (Print Publication: 2018).
Typ publikacji:
Journal Article
MeSH Terms:
Dengue/*epidemiology
Disease Notification/*statistics & numerical data
Data Interpretation, Statistical ; Humans ; Models, Biological ; Population Surveillance ; Public Health ; Puerto Rico/epidemiology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Clinical and epidemiologic characteristics of dengue and other etiologic agents among patients with acute febrile illness, Puerto Rico, 2012-2015.
Autorzy:
Tomashek KM; Dengue Branch, Division of Vector-Borne Diseases, Centers for Disease Control and Prevention (CDC), San Juan, Puerto Rico, United States of America.
Lorenzi OD; Dengue Branch, Division of Vector-Borne Diseases, Centers for Disease Control and Prevention (CDC), San Juan, Puerto Rico, United States of America.
Andújar-Pérez DA; Ponce Health Sciences University/Saint Luke's Episcopal Hospital, Ponce, Puerto Rico, United States of America.
Torres-Velásquez BC; Dengue Branch, Division of Vector-Borne Diseases, Centers for Disease Control and Prevention (CDC), San Juan, Puerto Rico, United States of America.
Hunsperger EA; Dengue Branch, Division of Vector-Borne Diseases, Centers for Disease Control and Prevention (CDC), San Juan, Puerto Rico, United States of America.
Munoz-Jordan JL; Dengue Branch, Division of Vector-Borne Diseases, Centers for Disease Control and Prevention (CDC), San Juan, Puerto Rico, United States of America.
Perez-Padilla J; Dengue Branch, Division of Vector-Borne Diseases, Centers for Disease Control and Prevention (CDC), San Juan, Puerto Rico, United States of America.
Rivera A; Dengue Branch, Division of Vector-Borne Diseases, Centers for Disease Control and Prevention (CDC), San Juan, Puerto Rico, United States of America.
Gonzalez-Zeno GE; Dengue Branch, Division of Vector-Borne Diseases, Centers for Disease Control and Prevention (CDC), San Juan, Puerto Rico, United States of America.
Sharp TM; Dengue Branch, Division of Vector-Borne Diseases, Centers for Disease Control and Prevention (CDC), San Juan, Puerto Rico, United States of America.
Galloway RL; Bacterial Special Pathogens Branch, Zoonoses and Select Agent Laboratory, CDC, Atlanta, Georgia, United States of America.
Glass Elrod M; Bacterial Special Pathogens Branch, Zoonoses and Select Agent Laboratory, CDC, Atlanta, Georgia, United States of America.
Mathis DL; Bacterial Special Pathogens Branch, Zoonoses and Select Agent Laboratory, CDC, Atlanta, Georgia, United States of America.
Oberste MS; Polio and Picornavirus Laboratory Branch, Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, CDC, Atlanta, Georgia, United States of America.
Nix WA; Polio and Picornavirus Laboratory Branch, Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, CDC, Atlanta, Georgia, United States of America.
Henderson E; Polio and Picornavirus Laboratory Branch, Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, CDC, Atlanta, Georgia, United States of America.
McQuiston J; Rickettsial Zoonoses Branch, Division of Vector-Borne Diseases, CDC, Atlanta, Georgia, United States of America.
Singleton J; Rickettsial Zoonoses Branch, Division of Vector-Borne Diseases, CDC, Atlanta, Georgia, United States of America.
Kato C; Rickettsial Zoonoses Branch, Division of Vector-Borne Diseases, CDC, Atlanta, Georgia, United States of America.
García Gubern C; Ponce Health Sciences University/Saint Luke's Episcopal Hospital, Ponce, Puerto Rico, United States of America.
Santiago-Rivera W; Ponce Health Sciences University/Saint Luke's Episcopal Hospital, Ponce, Puerto Rico, United States of America.
Cruz-Correa J; Ponce Health Sciences University/Saint Luke's Episcopal Hospital, Ponce, Puerto Rico, United States of America.
Muns-Sosa R; Saint Luke's Episcopal Hospital, Guayama, Puerto Rico, United States of America.
Ortiz-Rivera JD; Saint Luke's Episcopal Hospital, Guayama, Puerto Rico, United States of America.
Jiménez G; Saint Luke's Episcopal Hospital, Guayama, Puerto Rico, United States of America.
Galarza IE; Ponce Health Sciences University/Saint Luke's Episcopal Hospital, Ponce, Puerto Rico, United States of America.
Horiuchi K; Office of the Director, Division of Vector-Borne Diseases, CDC, Fort Collins, Colorado, United States of America.
Margolis HS; Dengue Branch, Division of Vector-Borne Diseases, Centers for Disease Control and Prevention (CDC), San Juan, Puerto Rico, United States of America.
Alvarado LI; Ponce Health Sciences University/Saint Luke's Episcopal Hospital, Ponce, Puerto Rico, United States of America.
Pokaż więcej
Źródło:
PLoS neglected tropical diseases [PLoS Negl Trop Dis] 2017 Sep 13; Vol. 11 (9), pp. e0005859. Date of Electronic Publication: 2017 Sep 13 (Print Publication: 2017).
Typ publikacji:
Journal Article
MeSH Terms:
Chikungunya Fever/*epidemiology
Dengue/*epidemiology
Fever/*epidemiology
Fever/*etiology
Influenza, Human/*epidemiology
Acute Disease ; Adolescent ; Adult ; Age Distribution ; Aged ; Aged, 80 and over ; Child ; Child, Preschool ; Chronic Disease/epidemiology ; Female ; Headache/etiology ; Humans ; Infant ; Infant, Newborn ; Leukopenia/etiology ; Male ; Middle Aged ; Prospective Studies ; Puerto Rico/epidemiology ; Sex Distribution ; Thrombocytopenia/etiology ; Young Adult
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Enhanced Surveillance for Fatal Dengue-Like Acute Febrile Illness in Puerto Rico, 2010-2012.
Autorzy:
Tomashek KM; Dengue Branch, Division of Vector-Borne Diseases, Centers for Disease Control and Prevention (CDC), San Juan, Puerto Rico.
Rivera A; Dengue Branch, Division of Vector-Borne Diseases, Centers for Disease Control and Prevention (CDC), San Juan, Puerto Rico.
Torres-Velasquez B; Dengue Branch, Division of Vector-Borne Diseases, Centers for Disease Control and Prevention (CDC), San Juan, Puerto Rico.
Hunsperger EA; Dengue Branch, Division of Vector-Borne Diseases, Centers for Disease Control and Prevention (CDC), San Juan, Puerto Rico.
Munoz-Jordan JL; Dengue Branch, Division of Vector-Borne Diseases, Centers for Disease Control and Prevention (CDC), San Juan, Puerto Rico.
Sharp TM; Dengue Branch, Division of Vector-Borne Diseases, Centers for Disease Control and Prevention (CDC), San Juan, Puerto Rico.
Rivera I; Puerto Rico Institute of Forensic Sciences, San Juan, Puerto Rico.
Sanabria D; Puerto Rico Institute of Forensic Sciences, San Juan, Puerto Rico.
Blau DM; Infectious Diseases Pathology Branch, Division of High Consequence Pathogens and Pathology, CDC, Atlanta, Georgia, United States of America.
Galloway R; Bacterial Special Pathogens Branch, Division of High Consequence Pathogens, CDC, Atlanta, Georgia, United States of America.
Torres J; Puerto Rico Institute of Forensic Sciences, San Juan, Puerto Rico.
Rodriguez R; Puerto Rico Institute of Forensic Sciences, San Juan, Puerto Rico.
Serrano J; Puerto Rico Institute of Forensic Sciences, San Juan, Puerto Rico.
Chávez C; Puerto Rico Institute of Forensic Sciences, San Juan, Puerto Rico.
Dávila F; Puerto Rico Institute of Forensic Sciences, San Juan, Puerto Rico.
Perez-Padilla J; Dengue Branch, Division of Vector-Borne Diseases, Centers for Disease Control and Prevention (CDC), San Juan, Puerto Rico.
Ellis EM; Dengue Branch, Division of Vector-Borne Diseases, Centers for Disease Control and Prevention (CDC), San Juan, Puerto Rico.
Caballero G; Demographic Registry of Puerto Rico, San Juan, Puerto Rico.
Wright L; Geospatial Research, Analysis, and Services Program, Division of Toxicology and Human Health Sciences, ATSDR, Atlanta, Georgia, United States of America.
Zaki SR; Infectious Diseases Pathology Branch, Division of High Consequence Pathogens and Pathology, CDC, Atlanta, Georgia, United States of America.
Deseda C; Puerto Rico Department of Health, San Juan, Puerto Rico.
Rodriguez E; Puerto Rico Institute of Forensic Sciences, San Juan, Puerto Rico.
Margolis HS; Dengue Branch, Division of Vector-Borne Diseases, Centers for Disease Control and Prevention (CDC), San Juan, Puerto Rico.
Pokaż więcej
Źródło:
PLoS neglected tropical diseases [PLoS Negl Trop Dis] 2016 Oct 11; Vol. 10 (10), pp. e0005025. Date of Electronic Publication: 2016 Oct 11 (Print Publication: 2016).
Typ publikacji:
Journal Article
MeSH Terms:
Epidemiological Monitoring*
Dengue/*mortality
Disease Outbreaks/*statistics & numerical data
Acute Disease/epidemiology ; Adolescent ; Adult ; Coinfection/epidemiology ; Dengue/epidemiology ; Dengue/virology ; Dengue Virus/genetics ; Dengue Virus/immunology ; Dengue Virus/isolation & purification ; Female ; Humans ; Leptospira/genetics ; Leptospira/immunology ; Leptospirosis/epidemiology ; Leptospirosis/microbiology ; Male ; Medical Records ; Middle Aged ; Mortality ; Puerto Rico/epidemiology ; Time Factors ; West Nile virus/genetics ; West Nile virus/immunology ; Young Adult
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Wyświetlanie 1-20 z 47

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies